Showing results (431-440 of 578) with videos related to
Sort By:
Pageof 58
Particle and Fibre Toxicology|December 6, 2008
Exposure to ultrafine carbon particles at levels below detectable pulmonary inflammation affects cardiovascular performance in spontaneously hypertensive ratsSwapna Upadhyay, Tobias Stoeger, Volkar Harder, et al.Neuropeptides|June 8, 2020
Genetic deletion of the angiotensin-(1-7) receptor Mas leads to alterations in gut villi length modulating TLR4/PI3K/AKT and produces microbiome dysbiosisLuis Paulo Oliveira, Victor Hugo Dantas Guimarães, Janaina Ribeiro Oliveira, et al.Archives of Toxicology|July 3, 2026
Scientific approach to derive occupational exposure limits for formaldehyde releasersSandra Michaelsen, Britta Laube, Rüdiger Bartsch, et al.Frontiers in Physiology|April 14, 2022
Oxidative RNA Damage in the Pathogenesis and Treatment of Type 2 DiabetesXiatian Chen, Hua Yu, Zhe Li, et al.Mediators of Inflammation|July 31, 2019
Nephropathy in Hypertensive Animals Is Linked to M2 Macrophages and Increased Expression of the YM1/Chi3l3 ProteinPaula Andréa Malveira Cavalcante, Natalia Alenina, Alexandre Budu, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 8, 2016
Effects of ACE2 deficiency on physical performance and physiological adaptations of cardiac and skeletal muscle to exerciseDaisy Motta-Santos, Robson Augusto Souza Dos Santos, Marilene Oliveira, et al.Plos One|February 4, 2010
Alternative splicing and extensive RNA editing of human TPH2 transcriptsMaik Grohmann, Paul Hammer, Maria Walther, et al.International Journal of Hypertension|February 10, 2012
Renoprotective Effects of AVE0991, a Nonpeptide Mas Receptor Agonist, in Experimental Acute Renal InjuryLívia Corrêa Barroso, Kátia Daniela Silveira, Cristiano Xavier Lima, et al.Journal of Molecular Medicine (Berlin, Germany)|February 5, 2017
Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin IIChristoph Maier, Ines Schadock, Philipp K Haber, et al.Journal of Medicinal Chemistry|October 31, 2023
Structure-Based Design of Xanthine-Imidazopyridines and -Imidazothiazoles as Highly Potent and In Vivo Efficacious Tryptophan Hydroxylase InhibitorsEdgar Specker, Radoslaw Wesolowski, Anja Schütz, et al.Pageof 58